Genistein aglycone: A new therapeutic approach to reduce endometrial hyperplasia
Genistein aglycone: A new therapeutic approach to reduce endometrial hyperplasia
About this item
Full title
Author / Creator
Publisher
Germany: Elsevier GmbH
Journal title
Language
English
Formats
Publication information
Publisher
Germany: Elsevier GmbH
Subjects
More information
Scope and Contents
Contents
Endometrial hyperplasia without cytological atypia is commonly treated with progestins, but other treatment regimes may be available with equivalent efficacy and low side effects.
A randomized double-blind, placebo and progesterone-controlled clinical trial to evaluate the effects of genistein aglycone in reducing endometrial hyperplasia.
A g...
Alternative Titles
Full title
Genistein aglycone: A new therapeutic approach to reduce endometrial hyperplasia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_753996962
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_753996962
Other Identifiers
ISSN
0944-7113
E-ISSN
1618-095X
DOI
10.1016/j.phymed.2010.03.024
